PainChek Ltd
ASX:PCK
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| AU |
|
PainChek Ltd
ASX:PCK
|
35.5m AUD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.2B USD |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
13.9B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
5.1B USD |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
4.7B USD |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
41.3B SEK |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
21.4B CNY |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
223.4B INR |
Loading...
|
Market Distribution
| Min | -6 907 100% |
| 30th Percentile | 21.6% |
| Median | 38.3% |
| 70th Percentile | 58.2% |
| Max | 2 095.9% |
Other Profitability Ratios
PainChek Ltd
Glance View
PainChek Ltd. engages in the development and commercialisation of mobile medical device applications. The company is headquartered in Sydney, New South Wales. The company went IPO on 2012-05-01. The Company’s principal activities are development and commercialization of mobile medical device applications, that automate intelligent pain assessment of individuals who are unable to communicate their pain with carers. Its Paincheck is an Adult and Infant pain assessment applications. Its PainChek technology uses cameras in smartphones and tablets to capture a brief video of the person, which is analyzed in real time using facial recognition software to detect the presence of facial micro-expressions that are indicative of the presence of pain. Its Paincheck uses artificial intelligence (AI) to automatically assess the micro-facial features of pain. Its PainChek technology has multiple regulatory clearances, including TGA (Australia) and CE Mark (Europe) for use as a class 1 medical device to assess pain in people who are unable to reliably verbalize, such people with dementia.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for PainChek Ltd is 29.7%, which is below its 3-year median of 32.1%.
Over the last 3 years, PainChek Ltd’s Gross Margin has increased from -24.5% to 29.7%. During this period, it reached a low of -24.5% on Jun 30, 2022 and a high of 38.8% on Dec 31, 2023.
